Navigation Links
InfuSystem Holdings, Inc. Terminates "Poison Pill" Plan
Date:6/8/2012

MADISON HEIGHTS, Mich., June 8, 2012 /PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE MKT: INFU), the leading national provider of infusion pumps and related services for the healthcare industry, said today it had formally amended the Company's stockholder rights plan to accelerate the final expiration date of the associated purchase rights issued in the plan, as previously announced on May 30, 2012.

This amendment effectively terminates the stockholder rights plan, typically referred to as a "poison pill."

Under the terms of the amendment, the purchase rights expired at the close of business on June 8, 2012, rather than in November 2020 as in the original rights agreement.

"This step further affirms the Board's commitment to transparent communication and strong shareholder governance practices, and was not made in connection with any proposed or expected transaction," stated Ryan Morris, Executive Chairman.

About InfuSystem Holdings, Inc.

InfuSystem Holdings, Inc. is the leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers.  Headquartered in Madison Heights, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, and Ontario, Canada.  The Company's stock is traded on the NYSE MKT under the symbol INFU.

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those predicted by such forward-looking statements.  These risks and uncertainties include general economic conditions, as well as other risks, detailed from time to time in the Company's publicly filed documents.

Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.

INVESTOR CONTACT:
Jonathan P. Foster
Chief Financial Officer
Info@InfuSystem.com
800-962-9656


'/>"/>
SOURCE InfuSystem Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. InfuSystem Holdings Modifies Bylaws to Align with Corporate Governance Best Practices
2. InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012
3. InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders
4. InfuSystem Holdings, Inc. To Announce First Quarter 2012 Financial Results On May 21, 2012
5. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... and GENEVA , March ... on World Tuberculosis Day revitalizes efforts to develop sutezolid ... On World Tuberculosis Day, TB Alliance and the ... the clinical development of sutezolid, an antibiotic drug candidate ... pertains to the development of sutezolid in combination with ...
(Date:3/23/2017)... DUBLIN , Mar. 23, 2017 Research ... Valve Devices Market: Analysis By Procedure, Replacement Procedure By Technique, Repair ... their offering. ... Global Heart Valve Devices Market is forecasted to grow at a ... heart valve devices is driven by rising aging population, growth in ...
(Date:3/23/2017)... , March 23, 2017  The U.S. Food and ... for the treatment of adults and pediatric patients 12 ... including those who have not received prior chemotherapy. This ... rare, aggressive form of skin cancer. "While ... patients with a rare form called Merkel cell cancer ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... 2017 , ... “Finding Christ Through Social Media: Year One ... the writer’s path toward true communion with God. “Finding Christ Through Social Media: ... creation of published author Lea Michelle Johnson, a follower of Christ, wife and ...
(Date:3/23/2017)... ... 2017 , ... In 2016 the World Health Organization declared the Zika virus ... Zika-related cases in the Americas within the next year. Lyme disease is one of ... skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect borne illnesses are ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... Oklahoma City Convention Center at 10 North Broadway Avenue, will be an educational ... of relevant, practical instruction in the management of chronic pain. , Oklahoma is ...
(Date:3/23/2017)... , ... March 23, 2017 , ... March is National ... pack a punch when it comes to maintaining good health. Every day, two kidneys ... your kidneys filter every drop of your blood, eliminating waste, regulating fluid levels and ...
(Date:3/23/2017)... AZ (PRWEB) , ... March 23, 2017 , ... The ... people around the world to manage stress and anxiety. , “Buzzies change the ... neuropsychologist, inventor and co-founder of Buzzies. , Since its launch date in December 2016, ...
Breaking Medicine News(10 mins):